Copyright
©The Author(s) 2023.
World J Gastroenterol. Jun 21, 2023; 29(23): 3622-3644
Published online Jun 21, 2023. doi: 10.3748/wjg.v29.i23.3622
Published online Jun 21, 2023. doi: 10.3748/wjg.v29.i23.3622
Figure 11 Diagram of the mechanism of 18β-glycyrrhetinic acid therapy for gastric cancer cells.
18β-GRA: 18β-glycyrrhetinic acid; mTOR: Mammalian target of rapamycin; Bcl-2: B-cell lymphoma 2; NBR1: Neighbor of BRCA1 gene 1; PE: Phosphatidylethanolamine.
- Citation: Li X, Ma XL, Nan Y, Du YH, Yang Y, Lu DD, Zhang JF, Chen Y, Zhang L, Niu Y, Yuan L. 18β-glycyrrhetinic acid inhibits proliferation of gastric cancer cells through regulating the miR-345-5p/TGM2 signaling pathway. World J Gastroenterol 2023; 29(23): 3622-3644
- URL: https://www.wjgnet.com/1007-9327/full/v29/i23/3622.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i23.3622